MedCon 2025 has been announced!

April 23 - 25, 2025

Columbus, OH

AFDO RAPS Healthcare Products Collaborative
Presents
MedCon Conference

Back to

2024 MedCon Agenda

April 24, 2024 @ 12:05 pm

-

1:30 pm

Harnessing the Power of Advances in Clinical Evidence

Pre Market Track

In the last few years, FDA has issued several guidance documents related to evidence generation for medical devices. This session is designed to explore these draft guidance documents, offering attendees a roadmap on how clinical evidence is being used to broaden diversity in studies and achieve streamlined and expedited evidence generation and review process.

Moderator

Shannon Hoste, Chief Scientific Officer, Pathway for Patient Health

Speaker

Felipe Aguel, Deputy Director, Office of Clinical Evidence and Analysis, Center for Devices and Radiological Health (CDRH), FDA
Daniel Canos, Director, Office of Clinical Evidence and Analysis, Center for Devices and Radiological Health (CDRH), FDA
Paul Coplan, Vice President and Global Head, Medical Device Epidemiology, Johnson & Johnson MedTech
Tom McLain, President, Renalytix
Simon Mason, President, National Evaluation System for health Technology Coordinating Center (NESTcc) part of MDIC

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative